Cargando…

Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”

Detalles Bibliográficos
Autor principal:	Dhakal, Sandesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472803/ https://www.ncbi.nlm.nih.gov/pubmed/36163207 http://dx.doi.org/10.1016/j.hrtlng.2022.09.004

Ejemplares similares

Comment on “Pre-hospital antiplatelet medication use on COVID-19 disease severity”
por: Nadeem, Arsalan, et al.
Publicado: (2022)

Pre-hospital antiplatelet medication use on COVID-19 disease severity
por: Pan, Darren, et al.
Publicado: (2021)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Comment on “Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study”
por: Yang, Qunying, et al.
Publicado: (2021)

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

Comments on: COVID-19 pandemic – Testing times for postgraduate medical education
por: Gurnani, Bharat, et al.
Publicado: (2021)

Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment
por: Rossio, Raffaella, et al.
Publicado: (2021)

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Ding, Ze-yang, et al.
Publicado: (2021)

High-dose steroids for the treatment of severe COVID-19: comment
por: Tanaka, Shuichi, et al.
Publicado: (2021)

Pre-Hospital Trauma Care in the COVID-19 era
por: Mazzoli, Carlo Alberto, et al.
Publicado: (2020)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Arterial Embolic Infarction After COVID-19 Vaccination Associated With Antiplatelet Factor 4 Antibody
por: Park, Kwan Young, et al.
Publicado: (2022)

Comment on: COVID-19 and abortion right
por: Omidinia, Eskandar
Publicado: (2021)

COVID-19 and smoking: A comment
por: Joob, Beuy, et al.
Publicado: (2021)

Comment on: COVID-19 and abortion right
por: Madani, Seyyed Javad, et al.
Publicado: (2021)

Comment on an article: “Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective”
por: Ibrahimagić, Omer Ć., et al.
Publicado: (2020)

Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience
por: Rakowski, Tomasz, et al.
Publicado: (2013)

Comment on: Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19
por: Mahfooz, Kamran
Publicado: (2023)

Comment: Personal protective equipment use in laparoscopy during COVID-19
por: Baksi, Aditya, et al.
Publicado: (2021)

Vorapaxar: The missing link in antiplatelet therapy!
por: Nair, Abhijit S.
Publicado: (2017)

Comment on “Association-19 of body mass index with COVID-19 related in-hospital death” Clinical Nutrition 2022
por: Santos de Sousa Fernandes, Matheus, et al.
Publicado: (2022)

Comment on Determinants of the Attitude to COVID-19 Vaccine
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Comment on “COVID-19, the Built Environment, and Health”
por: Erren, Thomas C., et al.
Publicado: (2021)

Comment on “Unclear Issues Regarding COVID-19”
por: Sheikh, Sadaf
Publicado: (2021)

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
por: Togano, Tomiteru, et al.
Publicado: (2021)

Comments on: Neuro-ophthalmic presentation of COVID-19 disease: A case report
por: Finsterer, Josef
Publicado: (2021)

Response to comments on: Teleconsultation at a tertiary care government medical university during COVID-19 Lockdown
por: Pandey, Nitika, et al.
Publicado: (2021)

COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy
por: Coulson, J.M., et al.
Publicado: (2022)

Comment on “Increased in-hospital mortality from COVID-19 in patients with schizophrenia”. Considering the prevalence and protective factors of COVID-19 in patients with schizophrenia
por: Ekinci, O., et al.
Publicado: (2022)

Stopping “transient ischemic attacks” by antiplatelet withdrawal
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Comment to: Teleconsultation of infant rheumatology in COVID-19 time
por: Qanneta, Rami
Publicado: (2023)

COVID-19 vaccine-associated autoimmune disorders: Comments
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on "Knowledge, Attitude, and Acceptability of COVID-19 Vaccine"
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on an article: “Osteoporosis in the age of COVID-19 patients”
por: Ibrahimagić, O. Ć., et al.
Publicado: (2021)

COVID-19 and the dental damage stage: a comment
por: Mungmunpuntipantip, Rujitika, et al.
Publicado: (2021)

Peripheral Blood Smears in COVID-19: A Comment
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
por: Singh, Awadhesh K, et al.
Publicado: (2021)

Acetylsalicylic Acid and COVID-19 Prevention: A Comment
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bblhjg6u2drernoadb548um6in